KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) EPS (Basic): 2016-2024

Historic EPS (Basic) for Aurinia Pharmaceuticals (AUPH) over the last 9 years, with Dec 2024 value amounting to $0.04.

  • Aurinia Pharmaceuticals' EPS (Basic) rose 140.00% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.58, marking a year-over-year increase of 486.67%. This contributed to the annual value of $0.04 for FY2024, which is 107.41% up from last year.
  • According to the latest figures from FY2024, Aurinia Pharmaceuticals' EPS (Basic) is $0.04, which was up 107.41% from -$0.54 recorded in FY2023.
  • Aurinia Pharmaceuticals' EPS (Basic)'s 5-year high stood at $0.04 during FY2024, with a 5-year trough of -$1.40 in FY2021.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.54 (2023), whereas its average is -$0.42.
  • In the last 5 years, Aurinia Pharmaceuticals' EPS (Basic) plummeted by 60.92% in 2021 and then soared by 107.41% in 2024.
  • Yearly analysis of 5 years shows Aurinia Pharmaceuticals' EPS (Basic) stood at -$0.87 in 2020, then tumbled by 60.92% to -$1.40 in 2021, then surged by 45.71% to -$0.76 in 2022, then rose by 28.95% to -$0.54 in 2023, then soared by 107.41% to $0.04 in 2024.